子宫内膜癌幸存者随访护理(ENSURE):少即是多?评估减少随访方案的患者满意度与成本效果:随机对照试验研究方案
本研究为多中心随机对照试验,纳入荷兰282例1A和1B期低危子宫内膜癌且无辅助放疗指征的患者,随机分为干预组(3年内4次随访)和对照组(5年内10-13次随访,按荷兰指南)。主要结局为随访护理满意度和成本效果,次要结局包括医疗使用、依从性、健康相关生活质量、复发恐惧、焦虑抑郁、信息提供、复发和生存。预期干预组满意度相似但医疗使用和成本更低,成本节约。
要点
- 低危子宫内膜癌减少随访频率可能不影响满意度和结局。
- 干预组3年4次随访,对照组5年10-13次随访。
- 主要评估患者满意度和成本效果。
核心结论
- 预期干预组随访满意度与对照组相似,但医疗使用和成本更低。
- 减少随访方案在荷兰实施预计可节省成本,且不差异质量调整生命年和满意度。
研究设计与样本
- 多中心随机对照试验,纳入荷兰282例1A和1B期低危子宫内膜癌无辅助放疗指征患者。
- 干预组3年内4次随访,对照组按荷兰指南5年内10-13次随访。
- 基线及6、12、36、60个月填写问卷。
关键数值与推荐
- 主要结局为患者随访护理满意度和成本效果。
- 次要结局包括医疗使用、随访依从性、健康相关生活质量、复发恐惧、焦虑抑郁、信息提供、复发和生存。
- 采用线性回归分析比较两组随访满意度差异。
临床怎么用
- 为低危子宫内膜癌幸存者减少随访频率提供满意度和成本效果证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has often been hypothesized that the frequency of follow-up visits for patients with early-stage endometrial cancer could be decreased. However, studies evaluating effects of a reduced follow-up schedule among this patient group are lacking. The aim of this study is to assess patient satisfaction and cost-effectiveness of a less frequent follow-up schedule compared to the schedule according to the Dutch guideline. METHODS: In this multicenter randomized controlled trial, patients diagnosed in the Netherlands with stage 1A and 1B low-risk endometrial cancer, for whom adjuvant radiotherapy is not indicated (n = 282), are randomized. Patients allocated to the intervention group receive four follow-up visits during three years. Patients allocated to the control group receive 10-13 follow-up visits during five years, according to the Dutch guideline. Patients are asked to fill out a questionnaire at baseline and after 6, 12, 36, and 60 months. Primary outcomes include patient satisfaction with follow-up care and cost-effectiveness. Secondary outcomes include healthcare use, adherence to schedule, health-related quality of life, fear of recurrence, anxiety and depression, information provision, recurrence, and survival. Linear regression analyses will be used to assess differences in patient satisfaction with follow-up care between intervention and control group. DISCUSSION: We anticipate that patients in the intervention arm have a similar satisfaction with follow-up care and overall outcomes, but lower healthcare use and costs than patients in the control arm. No differences are expected in quality-adjusted life-years and satisfaction, but the reduced schedule is expected to be cost-saving when implemented in the Netherlands. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02413606 . Registered on 10 April 2015.
引用
- Ezendam NPM, de Rooij BH, Kruitwagen RFPM, et al. ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial. Trials. 2018. PMID: 29661218. doi:10.1186/s13063-018-2611-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。